LATEST NEWS
October, 2012
iSonea Files FDA Submission for Over-the-Counter SonoSentryâ„¢
September, 2012
2012 Annual Report
Letter to Eligible Shareholders on Rights Issue
Letter to Ineligible Shareholders on Rights Issue
iSonea Announces Fully Underwritten Renounceable Rights Issue to Raise $4M
Appendix 3B: application for quotation of additional securities and agreement
Prospectus: Offer to Eligible Shareholders
Letter to Option Holders
iSonea App Now Free
August, 2012
Preliminary Final Report
Bruce Mathieson Becomes Cornerstone Investor of iSonea
Application for Quotation of Additional Securities and Agreement
Change of Director’s Interest Notice
For business inquiries: iSonea Limited P.O. Box 990 Millersville, Maryland 21108-9998 USA Email: [email protected]
For product inquiries or technical support: iSonea Limited 1716 Ord Way Oceanside, California 92056 USA Tel. +1 760.297.6055 Email: [email protected]
© 2012 iSonea (formerly Karmelsonix) Ltd| Disclaimer, Terms and Conditions, Copyright and Intellectual Property.
CE Certification